19/02/2024.
IBM recently took part in the MPNE Consensus conference in Berlin, Germany.
19/02/2024.
IBM recently took part in the MPNE Consensus conference in Berlin, Germany.
16/02/2024.
The iToBoS project was presented at “XII Reunión Anual del Grupo Español de e-Dermatología e imagen (GEDEI)”, that took place in Madrid, Spain, on February 16th, 2024.
14/02/2024.
Partners in the iToBoS consortium recently had their work published in a peer reviewed scientific journal, entitled Frontiers in Digital Health.
12/02/2024.
Actors from different sectors, backgrounds and involvement with the acquisition, access and management of health data met in Berlin in the context of the MPNE 2024 Consensus in the framework of the iToBoS project.
10/02/2024.
What is Machine Unlearning? Basically, this concept represents the opposite of machine learning: it serves to make a model unlearn or forget.
9/02/2024.
The iToBoS project participated in the ISE Open Innovation Challenge 2024, an international B2B meeting event that took place both in Barcelona, in the venue of the ISE Congress, and online, between January 30 and February 8, 2024.
3/02/2024.
Melanoma Patient Network Europe is proud to announce the AI, Data, and Data-Dependent Business Models workshop took place in Berlin between 31 January and 2 February 2024 at Fraunhofer & Heinrich Hertz Institute in the framework of the iToBoS project
2/02/2024.
iToBoS project was present in the Integrated Systems Europe, an international exhibition dedicated to audio-visual and systems integration.
1/02/2024.
Presentation of the perspectives of generative Artificial Intelligence in melanoma at the MPNEconsensus 2024 by the iToBoS partner Leibniz University Hannover.
29/01/2024.
Dermoscopy is a powerful method used in dermatology to analyze the features of skin lesions.